Wang H, Xu W H, Liu J R, Peng Y, Peng X X, Wen X H, Tang X L, Xu H, Liu H, Shen Y L, Zhang X Y, Yang H M, Peng Y G, Li H M, Zhao S Y
Department Ⅱ of Respiratory Center, National Clinical Research Center for Respiratory Diseases, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Department of Radiology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Zhonghua Er Ke Za Zhi. 2024 Jul 2;62(7):669-675. doi: 10.3760/cma.j.cn112140-20231227-00466.
To investigate and summarize pediatric patients with severe pneumonia (MPP) presenting with varied clinical and chest imaging features in order to guide the individualized treatment. This was a retrospective cohort study. Medical records of clinical, imaging and laboratory data of 505 patients with MPP who were admitted to the Department Ⅱ of Respirology Center, Beijing Children's Hospital, Capital Medical University from January 2016 to October 2023 and met the enrollment criteria were included. They were divided into severe group and non-severe group according to whether lower airway obliterans was developed. The clinical and chest imaging features of the two groups were analyzed. Those severe cases with single lobe ≥2/3 consolidation (lobar consolidation) were further divided into subtype lung-necrosis and subtype non-lung-necrosis based on whether lung necrosis was developed. Comparison on the clinical manifestations, bronchoscopic findings, whole blood C-reactive protein (CRP) and other inflammatory indicators between the two subtypes was performed. Comparisons between two groups were achieved using independent-sample -test, nonparametric test or chi-square test. Univariate receiver operating characteristic (ROC) curve analyses were performed on the indicators such as CRP of the two subtypes. Of the 505 cases, 254 were male and 251 were female. The age of the onset was (8.2±2.9) years. There were 233 severe cases, among whom 206 were with lobar consolidation and 27 with diffuse bronchiolitis. The other 272 belonged to non-severe cases, with patchy, cloudy infiltrations or single lobe <2/3 uneven consolidation or localized bronchiolitis. Of the 206 cases (88.4%) severe cases with lobar consolidation, 88 harbored subtype lung-necrosis and 118 harbored subtype non-lung-necrosis. All 206 cases (100.0%) presented with persistent high fever, among whom 203 cases (98.5%) presented with inflammatory secretion obstruction and plastic bronchitis under bronchoscopy. Of those 88 cases with subtype lung-necrosis, there were 42 cases (47.7%) with dyspnea and 39 cases (44.3%) with moderate to massive amount of pleural effusion. There were 35 cases (39.8%) diagnosed with lung embolism during the disease course, of which other 34 cases (38.6%) were highly suspected. Extensive airway mucosal necrosis was observed in 46 cases (52.3%), and the level of their whole blood CRP was significantly higher than that of subtype non-lung-necrosis (131.5 (91.0, 180.0) 25.5 (12.0, 43.1) mg/L, =334.00, <0.001). They were regarded as subtype "lung consolidation-atelectasis-necrosis". Of those 118 cases with subtype non-lung-necrosis, 27 cases (22.9%) presented with dyspnea and none were with moderate to massive amount of pleural effusion. Sixty-five cases (55.1%) presented with plastic bronchitis and localized airway mucosal necrosis was observed in 32 cases (27.1%). They were deemed as subtype "lung consolidation-atelectasis". ROC curve analyses revealed that whole blood CRP of 67.5 mg/L on the 6-10 th day of disease course exhibited a sensitivity of 0.96, a specificity of 0.89, and an area under the curve of 0.97 for distinguishing between these two subtypes among those with lobar consolidation. Pediatric patients with severe MPP present with lobar consolidation or diffuse bronchiolitis on chest imaging. Those with lobar consolidation harbor 2 subtypes as "lung consolidation-atelectasis-necrosis" and "lung consolidation-atelectasis". Whole blood CRP of 67.5 mg/L can be applied as an early discriminating indicator to discriminate between these two subtypes.
为研究和总结表现出不同临床及胸部影像特征的小儿重症肺炎(MPP)患者,以指导个体化治疗。这是一项回顾性队列研究。纳入了2016年1月至2023年10月首都医科大学附属北京儿童医院呼吸中心二科收治的符合入选标准的505例MPP患者的临床、影像及实验室资料。根据是否发生下气道闭塞将其分为重症组和非重症组。分析两组的临床及胸部影像特征。将单叶≥2/3实变(大叶实变)的重症病例根据是否发生肺坏死进一步分为肺坏死亚型和非肺坏死亚型。对两种亚型的临床表现、支气管镜检查结果、全血C反应蛋白(CRP)及其他炎症指标进行比较。两组间比较采用独立样本t检验、非参数检验或卡方检验。对两种亚型的CRP等指标进行单因素受试者操作特征(ROC)曲线分析。505例患者中,男性254例,女性251例。发病年龄为(8.2±2.9)岁。重症病例233例,其中大叶实变206例,弥漫性细支气管炎27例。其余272例为非重症病例,表现为斑片状、云雾状浸润或单叶<2/3不均匀实变或局限性细支气管炎。206例(88.4%)大叶实变的重症病例中,肺坏死亚型88例,非肺坏死亚型118例。206例(100.0%)均有持续高热,其中203例(98.5%)支气管镜下有炎性分泌物阻塞及塑型性支气管炎。88例肺坏死亚型病例中,42例(47.7%)有呼吸困难,39例(44.3%)有中量至大量胸腔积液。病程中诊断为肺栓塞35例(39.8%),其中高度疑似34例(38.6%)。46例(52.3%)观察到广泛气道黏膜坏死,其全血CRP水平显著高于非肺坏死亚型(131.5(91.0,180.0)对25.5(12.0,43.1)mg/L,Z = 334.00,P < 0.001)。将其视为“肺实变-肺不张-坏死”亚型。118例非肺坏死亚型病例中,27例(22.9%)有呼吸困难,无中量至大量胸腔积液。65例(55.1%)有塑型性支气管炎,32例(27.1%)观察到局限性气道黏膜坏死。将其视为“肺实变-肺不张”亚型。ROC曲线分析显示,病程第6至10天全血CRP为67.5 mg/L时,区分大叶实变患者中这两种亚型的敏感度为0.96,特异度为0.89,曲线下面积为0.97。小儿重症MPP患者胸部影像表现为大叶实变或弥漫性细支气管炎。大叶实变患者有“肺实变-肺不张-坏死”和“肺实变-肺不张”两种亚型。全血CRP 67.5 mg/L可作为早期鉴别指标区分这两种亚型。